Join to View Full Profile
3855 Health Sciences DrLa Jolla, CA 92037
Phone+1 858-657-7876
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Yu-Wei Chen, MD, MS, is a board-certified medical oncologist who subspecializes in genitourinary (GU) oncology, treating prostate, kidney, bladder and testicular cancers. As a GU medical oncologist, Dr. Chen is trained in using systemic therapies (e.g., immunotherapy, targeted therapy, hormonal therapy, and chemotherapy) to treat patients with GU malignancies.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Cleveland Clinic FoundationResidency, Internal Medicine, 2016 - 2019
Harvard T. H. Chan School of Public HealthMS, Epidemiology, 2013 - 2015- National Cheng Kung University College of MedicineClass of 2012, MD
Certifications & Licensure
CA State Medical License 2019 - 2027
MA State Medical License 2019 - 2024
TN State Medical License 2020 - 2023
OH State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- The Robert A. Winn Diversity in Clinical Trials Career Development Award
- ASCO Young Investigator Award Conquer Cancer Foundation, 2022
- ASCO Merit Award Conquer Cancer Foundation, 2022
- Join now to see all
Publications & Presentations
PubMed
- CLO25-100: Improving Germline Testing in At-Risk Patients With Prostate Cancer.Juan Javier-DesLoges, Ana Flores Pimentel, Yu-Wei Chen, Yasoda Satpathy, James Michael Randall
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming.Ssu-Han Wang, Yu-Lin Chen, Shih-Han Huang, Yu-Ke Fu, Su-Fang Lin
Oncogenesis. 2025-03-11 - Emerging innovative treatment strategies for advanced clear cell renal cell carcinoma.Sharon H Choi, Yu-Wei Chen, Justine Panian, Kit Yuen, Rana R McKay
The Oncologist. 2025-03-10
Authored Content
- Treatment Options After First-Line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell CarcinomaDecember 2023
- Adjuvant Pembrolizumab After Nephrectomy in Renal Cell Carcinoma: Embracing the Promises and Acknowledging the UncertaintiesFebruary 2022
Press Mentions
Advanced Kidney Cancer Research: Insights from IKCS 2021December 4th, 2021
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin), Taiwanese
External Links
- UC San Diego Health Profilehttps://providers.ucsd.edu/details/1245694801/medical-oncology-urology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
